Follow
Automatic prediction of cognitive and functional decline can significantly decrease the number of subjects required for clinical trials in early Alzheimer's disease. (arXiv:2101.08346v1 [q-bio.QM]) http://arxiv.org/abs/2101.08346
Automatic prediction of cognitive and functional decline can significantly decrease the number of subjects required for clinical trials in early Alzheimer's disease. (arXiv:2101.08346v1 [q-bio.QM]) http://arxiv.org/abs/2101.08346